MAI Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-47
Closed -$5.54K 4145
2026
Q1
$5.54K Buy
47
+32
+213% +$4.47K ﹤0.01% 3466
2025
Q4
$2.46K Sell
15
-22
-59% -$3.45K ﹤0.01% 3361
2025
Q3
$4.95K Sell
37
-20
-35% -$2.43K ﹤0.01% 3018
2025
Q2
$7.09K Buy
57
+46
+418% +$5.85K ﹤0.01% 2898
2025
Q1
$1.4K Hold
11
﹤0.01% 3046
2024
Q4
$1.58K Buy
+11
New +$1.58K ﹤0.01% 3080

Other funds holding RGEN

MAI Capital Management's RGEN Position: Q2 2026 in Review

MAI Capital Management sold out of Repligen (RGEN) in Q2 2026, closing a stake of 47 shares — an estimated $5.54K sold.

MAI Capital Management first reported a position in RGEN in Q4 2024 and held it in 6 quarters. The position peaked at $7.09K in Q2 2025. 481 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • MAI Capital Management reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 47 Repligen shares in Q2 2026, an estimated $5.54K.
  • MAI Capital Management first reported a position in Repligen in Q4 2024 and held it in 6 quarters.
  • MAI Capital Management's Repligen position peaked at $7.09K in Q2 2025.
  • 481 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.